Songjiang Ma, President at GYRE THERAPEUTICS, INC. (GYRE), sold 4,000 shares at $11.43 ($46K) on 2025-01-29, disclosed to the SEC on 2025-01-31.
Scheduled sale ($46k) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.43 | 2,000 | $23K | 50.1% |
| 2 | $11.37 | 2,000 | $23K | 49.9% |
| Total | $11.40 avg | 4,000 | $46K | 100% |
| Filing → |
| GYRE | SELL | 2025-05-22 | $44K | — | Filing → |
| GYRE | SELL | 2025-05-20 | $45K | — | Filing → |
| GYRE | SELL | 2025-05-16 | $22K | — | Filing → |